about
Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in ZambiaHigh uptake of exclusive breastfeeding and reduced early post-natal HIV transmission.Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study.The influence of quality maternity waiting homes on utilization of facilities for delivery in rural ZambiaDoes severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants?PEPFAR's support for orphans and vulnerable children: some beneficial effects, but too little data, and programs spread thin.Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.Effects of early, abrupt weaning on HIV-free survival of children in Zambia.Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia.Willingness to Pay for a Maternity Waiting Home Stay in Zambia.In-home HIV testing and nevirapine dosing by traditional birth attendants in rural Zambia: a feasibility study.Listening to the community: Using formative research to strengthen maternity waiting homes in Zambia.Impact of maternity waiting homes on facility delivery among remote households in Zambia: protocol for a quasiexperimental, mixed-methods studyBuilding financial management capacity for community ownership of development initiatives in rural ZambiaEvaluating implementation effectiveness and sustainability of a maternity waiting homes intervention to improve access to safe delivery in rural Zambia: a mixed-methods protocolQuality and utilization patterns of maternity waiting homes at referral facilities in rural Zambia: A mixed-methods multiple case analysis of intervention and standard of care sites
P50
Q28535891-4A506E45-D90D-4B83-A9A6-77B88FC53214Q33312382-154927D5-DC80-4CA7-A350-12FFDB8BDBE2Q33652870-8B26FB45-38FC-47C2-B54B-C5619A401DF0Q33743262-93AF1F66-0BDA-4AF5-BCB5-018F09439E3EQ34313201-963147EE-6E9C-408D-B768-A095C994D9D9Q34331857-37AD3FCC-D266-4ABF-B246-2EDC712116AEQ35594099-3E92BC6A-CCE8-4787-8D1B-C82117FF541AQ36960424-6D19C8D2-73CC-41F5-8FB6-E9267C059995Q37435076-929A846A-E7BC-4584-9633-E9BC166BDA7DQ38832037-8E4DEBC9-A9E9-49B0-AADD-75F5413674F3Q42245051-8B6186E2-2869-4892-8EBE-9938DCC6A459Q52653985-5F4E3636-D26F-487B-B75D-D5D5C54D2F1AQ56523657-2AE00C92-E340-418C-BFA3-15F2F1143594Q64108397-56A6A3A9-AFA4-43E2-B474-540C66C890E1Q90274947-C04800C7-FBE1-4FAB-AABA-41BCAE7D5D75Q91488667-73A216A2-F41A-4457-A6ED-2E88925A4C59
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nancy Scott
@ast
Nancy Scott
@en
Nancy Scott
@es
Nancy Scott
@nl
Nancy Scott
@sl
type
label
Nancy Scott
@ast
Nancy Scott
@en
Nancy Scott
@es
Nancy Scott
@nl
Nancy Scott
@sl
prefLabel
Nancy Scott
@ast
Nancy Scott
@en
Nancy Scott
@es
Nancy Scott
@nl
Nancy Scott
@sl
P106
P21
P31
P496
0000-0002-4713-4642
P569
2000-01-01T00:00:00Z